Literature DB >> 16396631

Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.

Sudeep K Bose1, Tapas K Sengupta, Sumita Bandyopadhyay, Eleanor K Spicer.   

Abstract

The 3'-UTR (untranslated region) of bcl-2 mRNA contains an ARE (AU-rich element) that potentially regulates the stability of bcl-2 mRNA in a cell specific fashion. Previous studies have demonstrated that multiple proteins interact with bcl-2 mRNA in HL-60 (human leukaemia-60) cells, potentially contributing to the overexpression of Bcl-2 protein. Treatment of HL-60 cells with taxol or okadaic acid has been shown to induce destabilization of bcl-2 mRNA, which was associated with decreased binding of trans-acting factors to bcl-2 mRNA. Nucleolin has been identified as one of the bcl-2 mRNA-binding proteins [Sengupta, Bandyopadhyay, Fernandes and Spicer (2004) J. Biol. Chem. 279, 10855-10863]. In an effort to identify additional bcl-2 mRNA-binding proteins, two polypeptides of approx. 45 kDa and 60 kDa were isolated from HL-60 cells by ARE(bcl-2) (transcripts that contain bcl-2 AREs) RNA affinity chromatography. These proteins were identified as the human proliferation associated protein, Ebp1, and human DRBP76 (double stranded RNA-binding protein 76) respectively, by MALDI (matrix-assisted laser-desorption ionization)-MS. RNA electrophoretic mobility shift assays indicated that recombinant Ebp1 binds to ARE(bcl-2) RNA but not to the group 1 ARE present in GM-CSF (granulocyte macrophage-colony stimulating factor) mRNA in vitro. Antibody supershift assays demonstrated that Ebp1 is present in protein-ARE(bcl-2) RNA complexes formed with cytosolic HL-60 extracts. The interaction of Ebp1 with bcl-2 mRNA in HL-60 cells was also demonstrated by RNA co-immunoprecipitation assays. This interaction was not detected in extracts of taxol-treated HL-60 cells. Immunoprecipitation assays further revealed that Ebp1 co-precipitates with nucleolin from HL-60 cytoplasmic extracts. The observation that co-precipitation was decreased when extracts were treated with RNase suggests that Ebp1 and nucleolin are present in the same bcl-2 mRNP (messenger ribonucleoprotein particle) complexes. RNA-decay assays further demonstrated that Ebp1 decreased the rate of decay of beta-globin-ARE(bcl-2) transcripts in HL-60 cell extracts. Collectively, these results indicate a novel function for Ebp1 in contributing to the regulation of bcl-2 expression in HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16396631      PMCID: PMC1449993          DOI: 10.1042/BJ20051548

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stability.

Authors:  L P Ford; J Wilusz
Journal:  Methods       Date:  1999-01       Impact factor: 3.608

2.  Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4.

Authors:  J Lamartine; M Seri; R Cinti; F Heitzmann; M Creaven; N Radomski; E Jost; G M Lenoir; G Romeo; B S Sylla
Journal:  Cytogenet Cell Genet       Date:  1997

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 4.  AU-rich elements: characterization and importance in mRNA degradation.

Authors:  C Y Chen; A B Shyu
Journal:  Trends Biochem Sci       Date:  1995-11       Impact factor: 13.807

5.  Analysis of the AU-rich elements in the 3'-untranslated region of beta 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species.

Authors:  B G Tholanikunnel; J R Raymond; C C Malbon
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

Review 6.  Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

Authors:  J C Reed
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

7.  DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR.

Authors:  R C Patel; D J Vestal; Z Xu; S Bandyopadhyay; W Guo; S M Erme; B R Williams; G C Sen
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA.

Authors:  Yoko Otake; Tapas K Sengupta; Sumita Bandyopadhyay; Eleanor K Spicer; Daniel J Fernandes
Journal:  Mol Pharmacol       Date:  2004-10-18       Impact factor: 4.436

9.  Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle.

Authors:  N Radomski; E Jost
Journal:  Exp Cell Res       Date:  1995-10       Impact factor: 3.905

10.  Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein.

Authors:  F A Riordan; L Foroni; A V Hoffbrand; A B Mehta; R G Wickremasinghe
Journal:  FEBS Lett       Date:  1998-09-18       Impact factor: 4.124

View more
  28 in total

1.  Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.

Authors:  W Jiang; H Huang; L Ding; P Zhu; H Saiyin; G Ji; J Zuo; D Han; Y Pan; D Ding; X Ma; Y Zhang; J Wu; Q Yi; J O Liu; H Huang; Y Dang; L Yu
Journal:  Oncogene       Date:  2014-11-17       Impact factor: 9.867

2.  The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

Authors:  Smita Awasthi; Heather Ezelle; Bret A Hassel; Anne W Hamburger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

3.  Ebp1 isoforms distinctively regulate cell survival and differentiation.

Authors:  Zhixue Liu; Jee-Yin Ahn; Xia Liu; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

4.  Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1).

Authors:  Daniella Ishimaru; Lisa Zuraw; Sivakumar Ramalingam; Tapas K Sengupta; Sumita Bandyopadhyay; Adrian Reuben; Daniel J Fernandes; Eleanor K Spicer
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

5.  Expression, purification, crystallization and preliminary crystallographic analysis of the proliferation-associated protein Ebp1.

Authors:  Eva Kowalinski; Gert Bange; Klemens Wild; Irmgard Sinning
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-25

6.  EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.

Authors:  Yuexing Zhang; Douglas Linn; Zhenqiu Liu; Jonathan Melamed; Fabio Tavora; Charles Y Young; Angelika M Burger; Anne W Hamburger
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 7.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

8.  Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.

Authors:  Hua Zhou; Krystyna Mazan-Mamczarz; Jennifer L Martindale; Andrew Barker; Zhenqiu Liu; Myriam Gorospe; Peter J Leedman; Ronald B Gartenhaus; Anne W Hamburger; Yuexing Zhang
Journal:  Nucleic Acids Res       Date:  2010-02-16       Impact factor: 16.971

9.  Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.

Authors:  Yuexing Zhang; Damilola Akinmade; Anne W Hamburger
Journal:  Cancer Lett       Date:  2008-03-19       Impact factor: 8.679

10.  Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.

Authors:  Yuexing Zhang; Yan Lu; Hua Zhou; Myounghee Lee; Zhenqiu Liu; Bret A Hassel; Anne W Hamburger
Journal:  BMC Cell Biol       Date:  2008-12-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.